Auxilius Pharma
NY - BrooklynPharmaceutical
Focus: Auxilius Pharma is a specialty pharmaceutical company headquartered in Brooklyn, NY, focused on small molecule therapeutics in endocrinology. The company generates 100% of revenue from a single marketed product, XIAFLEX, indicating a highly concentrated and vulnerable business model.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Auxilius Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Auxilius Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$66M Part DDeclining
LOE Approaching
XIAFLEX is the company's only meaningful revenue driver, and approaching loss of exclusivity poses an existential threat to the business.
Help build intelligence for Auxilius Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.